SCHEMBL29909161

SCHEMBL29909161

c1ccc(N(CC2CCOCC2)c2nc3nncn3c3ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CREBBP Q92793 1/20 0.33
POLB P06746 1/20 0.33
CSF1R P07333 1/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.31
PER2 O15055 1/20 0.31
CYP2D6 P10635 2/20 0.31
HRH1 P35367 2/20 0.31
KCNH2 Q12809 2/20 0.31
CHRM1 P11229 1/20 0.31
CNR1 P21554 2/20 0.31
CNR2 P34972 2/20 0.31
FFAR2 O15552 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23576877 1.00 ALOX15 (0.33) ALOX15TSHRCREBBPPOLBCSF1R
SCHEMBL23577922 0.92 MAPT (0.34) ALOX15TSHRCREBBPPOLBMAPT
SCHEMBL29909251 0.92 MAPT (0.34) ALOX15TSHRCREBBPPOLBMAPT
SCHEMBL29909483 0.90 SMN1; SMN2 (0.35) ALOX15TSHRCREBBPMAPTKDM4E
SCHEMBL23577173 0.90 SMN1; SMN2 (0.35) ALOX15TSHRCREBBPMAPTKDM4E
SCHEMBL23577189 0.89 CRY1 (0.37) ALOX15TSHRCREBBPMAPTKDM4E
SCHEMBL29909554 0.89 CRY1 (0.37) ALOX15TSHRCREBBPMAPTKDM4E
SCHEMBL23576668 0.80 FGFR1 (0.33) MAPTSMN1; SMN2
SCHEMBL29909525 0.80 FGFR1 (0.33) MAPTSMN1; SMN2
SCHEMBL23577104 0.79 MAOA (0.38) ALOX15TSHRCREBBPPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12054490-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2024-08-06 US disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12054490-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK ALOX15 2014/4885TSHR 3739/4885CREBBP 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.